1NKEMIA Logo

1NKEMIA

Biotechnology company providing R&D and services for the life sciences sector.

IKM | BME Growth

Overview

Corporate Details

ISIN(s):
ES0156303002
LEI:
959800QRRHKJ6C8MW495
Country:
Spain
Address:
C/Alvarez de Castro 63, 08100 Mollet del Vallès

Description

1NKEMIA is a biotechnology company focused on generating high-value technological knowledge for the life sciences sector. The company's activities are structured around four main areas: Open R&D and innovation, technological services, specialized training, and the management of a knowledge capital fund. It provides services such as analytical development and validation to a diverse client base in the chemical, pharmaceutical, biotechnological, cosmetic, and nutraceutical industries. Operating as a group, 1NKEMIA also holds interests in various specialized companies to foster technological advancement and collaboration within its target markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all 1NKEMIA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 1NKEMIA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 1NKEMIA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-26 Björn Zethraeus Other Other 6,646 66,460,000.00 SEK
2025-05-24 Anders Nilsson Other Other 10,000 326,900.00 SEK
2025-05-23 marius balger Other Sell 45,000 534,150.00 SEK
2025-05-23 Todd Heringer Other Other 150,000 N/A
2025-05-22 Klaudija Cavala Other Other 100,000 22,000.00 SEK
2025-05-20 Gionata La Torre Other Buy 31,182 951,051.00 SEK
2025-05-20 Karl-Emil Engström Other Sell 5,000 279,350.00 SEK
2025-05-20 Christina Thérèse Hersch Fagerberg Other Sell 1,000 55,870.00 SEK
2025-05-20 Gionata La Torre Other Buy 31,182 N/A
2025-05-19 Erik Gjötterberg Other Other 15,000 311,550.00 SEK

Peer Companies

Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030
Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.